Elekta Has Repurchased Own Shares for SEK 100M

Elekta Has Repurchased Own Shares for SEK 100M

Stockholm Sweden — Thursday, February 7, 2008

During the period January 24 through February 8, 2008, Elekta has repurchased 951,300 B shares at an average price of SEK 105.11 totaling SEK 99,992,816.

These repurchases were carried out in line with the Board’s decision on February 23, 2008, to mandate the executive management to initiate repurchase of shares in an amount of SEK 100 M.

Elekta’s current holding of own shares (treasury stock) thereby amounts to 2,582,171 B shares.

The Annual General Meeting on September 25, 2007, resolved to cancel 1,630,871 of these shares and the cancellation process has started. The Board intends to propose to the next AGM that the recently repurchased 951,300 shares also should be cancelled.

The total number of shares in Elekta as of January 31, 2007 amounts to 93,903,316 divided between 3,562,500 A shares and 90,340,816 B shares.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time